This AMD Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts upgraded five stocks on Tuesday: Fluence Energy (UBS), Dynatrace (Morgan Stanley), Advanced Micro Devices/AMD (Raymond James), Summit Therapeutics (Bernstein), and Shift4 Payments (Wells Fargo). Key upgrades include AMD moving to Strong Buy with a raised price target of $641, and Dynatrace to Overweight at $65. Other changes involve rating shifts for Fluence, Summit, and Shift4.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- UBS analyst Jon Windham upgraded Fluence Energy Inc (NASDAQ:FLNC) from Sell to Neutral and raised the price target from $9 to $12. Fluence Energy closed at $10.86 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Sanjit Singh upgraded Dynatrace, Inc (NYSE:DT) from Equal-Weight to Overweight and boosted the price target from $58 to $65. Dynatrace shares closed at $49.05 on Monday. See how other analysts view this stock.
- Raymond James analyst Simon Leopold upgraded Advanced Micro Devices Inc (NASDAQ:AMD) from Outperform to Strong Buy and boosted the price target from $565 to $641. AMD closed at $456.74 on Monday. See how other analysts view this stock.
- Bernstein analyst Jeffrey Walch upgraded Summit Therapeutics Inc (NASDAQ:SMMT) from Underperform to Market Perform and raised the price target from $9.8 to $11.9. Summit Therapeutics shares closed at $12.73 on Monday. See how other analysts view this stock.
- Wells Fargo analyst Jason Kupferberg upgraded Shift4 Payments Inc (NYSE:FOUR) from Equal-Weight to Overweight and raised the price target from $55 to $59. Shift4 Payments closed at $48.00 on Monday. See how other analysts view this stock.
Considering buying AMD stock? Here’s what analysts think:
Photo via Shutterstock